SCHEMBL4040826

SCHEMBL4040826

COCCN(C)CCCOc1cc(OC2CCCC2)c2c(Nc3ccc(F)c(Cl)c3)ncnc2c1

nearest known ligand 0.72

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGFR P00533 19/20 0.72
SRC P12931 1/20 0.49
KDR P35968 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4034040 0.93 EGFR (0.83) EGFRSRCKDR
SCHEMBL4034245 0.91 EGFR (0.67) EGFRSRCKDR
SCHEMBL4037588 0.91 EGFR (0.76) EGFRSRCKDR
SCHEMBL4038425 0.91 EGFR (0.86) EGFRSRCKDR
SCHEMBL4034607 0.90 EGFR (0.85) EGFRSRCKDR
SCHEMBL4037419 0.90 EGFR (0.77) EGFRSRCKDR
SCHEMBL4037175 0.87 EGFR (0.72) EGFRSRCKDR
Hydrochloric Acid SCHEMBL4039545 0.87 EGFR (0.61) EGFR
SCHEMBL4034377 0.87 EGFR (0.77) EGFRSRCKDR
SCHEMBL4208330 0.87 EGFR (0.74) EGFRSRCKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444211-B1 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2009-01-21 EP disclosed
CN-1764651-A Quinazoline derivatives as antitumor agents ASTRAZENECA AB (SE) 2006-04-26 CN disclosed